COMMUNIQUÉS West-GlobeNewswire

CVRx to Present at the Jefferies Global Healthcare Conference in London
04/11/2025
MINNEAPOLIS, Nov. 04, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions [...]
Artelo Biosciences Announces Publication of Peer-Reviewed Article on Role of Fatty Acid Binding Proteins in Cancer
04/11/2025
Highlights Broad Development Potential of Proprietary Portfolio Targeting FABPs SOLANA BEACH, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company [...]
TELA Bio to Announce Third Quarter 2025 Financial Results
04/11/2025
MALVERN, Pa., Nov. 04, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today [...]
InStride Health Announces Key Leadership Additions, Promotions to Enhance Payer Engagement, Technical Enablement, and Clinical Operations
04/11/2025
With new and elevated leaders, InStride is poised to scale its care model while maintaining its differentiated specialty care BOSTON, Nov. 04, 2025 (GLOBE NEWSWIRE) -- InStride Health , a leading insurance-based [...]
Aligos Therapeutics to Present at Upcoming Investor Conferences
04/11/2025
SOUTH SAN FRANCISCO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies [...]
24/7 Market News- Kraig Labs’ Spider Silk Breakthrough Poised to Rival Nylon’s 1939 Revolution
04/11/2025
The Dawn of a New Fiber Era DENVER, Nov. 04, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com , a pioneer in digital media dedicated to the swift distribution of financial market news and information, reports that in 1939, [...]
BiomX Announces Positive FDA Feedback Supporting Next-Generation Phage Cocktail Program for Diabetic Foot Infections
04/11/2025
New FDA feedback confirms clinical pathway for fixed multi-phage cocktail BX011, expanding development into diabetic foot infections (DFI) and unlocking a major commercial opportunity NESS ZIONA, Israel, Nov. 04, 2025 ( [...]
Tango Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights
04/11/2025
– Data update from vopimetostat (TNG462) showed 2L MTAP-del pancreatic cancer median progression free survival (mPFS) 7.2 months– – Combination studies with RAS(ON) inhibitors ongoing, data anticipated 2026 – – 49% ORR [...]
RESET™ Clinical Trial Demonstrates Superior Pain Relief with SPRINT® PNS Compared to Standard Interventional Management for Chronic Low Back Pain
04/11/2025
The study met its Primary Endpoint of pain relief and showed that SPRINT PNS delivered significant improvements in patient-centric secondary endpoints CLEVELAND, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Published in the [...]
Renowned Pharma and Biotech Development Leader, Dr. Andreas Wallnöfer, is named to Optigo Biotherapeutics’ Board of Directors as the company advances to IND-enabling studies
04/11/2025
VANCOUVER, British Columbia, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Optigo Biotherapeutics (“ Optigo ”) , an ophthalmology company pioneering next-gen treatments for retinal diseases, today announced that Dr. Andreas [...]
WORK Medical Technology Group LTD’s Subsidiary Retains a US$114,000 Service Contract from GemPharmatech Corporation
04/11/2025
Hangzhou, China, Nov. 04, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) [...]
Marius Pharmaceuticals Leads Effort to Redefine Women’s Health Through Testosterone Research
04/11/2025
All-female advisory board to guide Marius in addressing the unmet need for safe, effective testosterone therapies for women RALEIGH, N.C., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, Inc. , today announced [...]
Compass Therapeutics Presents Preclinical Data on CTX-10726, a Differentiated PD-1 x VEGF-A Bispecific Antibody, at the 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting
04/11/2025
CTX-10726 demonstrated potent, simultaneous inhibition of tumor angiogenesis and PD-1-mediated immune suppression, and eliminated tumors in multiple preclinical studies. In vivo, CTX-10726 outperformed select [...]
Candel Therapeutics Showcases Immunotherapy Leadership at SITC 2025, Demonstrating Integration of Clinical Innovation, Multi-Omics, and Artificial Intelligence to Advance Next-Generation Immunotherapies in Solid Tumors
04/11/2025
Invited presentation followed by panel discussion on the next wave of innovation in immunotherapy of cancer: Paul Peter Tak, M.D., Ph.D., FMedSci, Candel’s President and CEO, will present the phase 3 clinical trial of [...]
Anathapindika Health Increases Stock Ahead of Expected U.S. Surge
04/11/2025
The Buddhist-Inspired Natural Health and Wellness Brand Has Increased Its Production in the Midst of a U.S. Rollout Fort Lauderdale, FL, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The United States has the biggest health and [...]
Crescent Biopharma to Present Preclinical Data for CR-001, a PD-1 x VEGF Bispecific Antibody, at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
04/11/2025
CR-001 Demonstrated Cooperative Pharmacology and Robust Anti-Tumor Activity IND Submission for CR-001 On Track for Fourth Quarter of 2025 to Support Initiation of Global Phase 1 Trial in Patients with Solid Tumors [...]
AIM ImmunoTech Announces Late Breaking Abstract from University of Pittsburgh Medical Center Accepted for Presentation at the 40th Annual Society for Immunotherapy of Cancer (SITC) Meeting
04/11/2025
OCALA, Fla., Nov. 04, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that data from the completed Phase 2 cisplatin-resistant advanced recurrent ovarian cancer [...]
PacBio Supports Berry Genomics in Achieving First Regulatory Approval for Clinical Long-Read Sequencing in China
04/11/2025
NMPA approval on the Sequel II CNDx system enables clinicians in China to harness PacBio HiFi sequencing for challenging conditions, with initial offering for thalassemia MENLO PARK, Calif., Nov. 04, 2025 (GLOBE [...]
Abalos Therapeutics to Present Preclinical Data Highlighting Potent, Synergistic Effects of ABX-001 in Combination with Bispecific T-cell Engagers at SITC 2025
04/11/2025
-- Combination with bispecific T-cell engagers amplifies T-cell recruitment and cytotoxic activity against tumor cells -- Düsseldorf, Germany, November 4, 2025 – Abalos Therapeutics announced today that it will present [...]

Pages